The Hidden Risk in Early Development: Why Programs Lose Momentum Webinar
Dr. Vince Clinical Research
0:00 / 0:00
The Hidden Risk in Early Development: Why Programs Lose Momentum Webinar
129 просмотров · 7 мес. назад
Dr. Vince Clinical Research
247 подписчиков
129 просмотров · 7 мес. назад
From First in Human through Proof of Concept, development is a continuous scientific narrative, yet operational handoffs often fragment that process. Discover how continuity in project leadership, study management and clinical monitoring influences execution quality, decision confidence and program momentum in early phase development.
In this webinar, experts from Dr. Vince Clinical Research (DVCR) will share perspectives on how continuity preserves institutional knowledge, reduces execution friction and helps programs maintain forward momentum.
This session is ideal for clinical operations, development and outsourcing leaders seeking to optimize early phase performance and drive more consistent, confident outcomes across their programs.
Speakers:
Beth Williams, Executive Director, Clinical Trial Services
Chris Hardage, Director, Clinical Trial Services
Crystal Sounakhen, Senior Study Manager
Chapters:
0:00 Intro
1:25 The Hidden Multiplier
2:04 The Sponsor Reality: Early Phase Is Not Modular
4:02 What gets lost in a handoff?
5:12 The Project Leader as the Program Memory
6:39 Study Execution vs Program Execution Models
8:23 Quantifying the Hidden Cost of PM Turnover
9:48 Continuity = Compounding Efficiency
11:02 Accountability is Structural, Not Personal
12:27 Study Management: The Continuity Sponsors Feel Every Day
14:44 The Hidden Cost of Turnover
15:40 How DVCR Resources Study Management
16:32 The Sponsor Perspective
17:46 End-to-End Monitoring Continuity
19:29 Monitoring is Where Protocol Meets Reality
21:40 Avoiding Common Industry Friction
22:52 Continuity Turns Monitoring from Policing to Performance Optimization
23:41 Monitoring Continuity: Structural Design Requirements
25:00 Tenure = Inspection Readiness
26:23 Reframe the Sponsor Question
28:00 The Phase 1b/2a Inflection
30:50 Tenure as a Delivery Signal (Not a Marketing Claim)
32:14 How Continuity Actually Works in Practice
33:33 Reframe the Sponsor Question
34:37 Q&A
45:22 Outro
#ClinicalResearch #EarlyPhaseDevelopment #ClinicalTrials #CROInsights #StudyManagement #ClinicalMonitoring #DrugDevelopment #ClinicalOperations